1e
19
1
49
2
2
18
1b
1d
18
37
59
1d
2 29
1d
25
Sunita D. Nasta, MD, FACP
78
59
Professor of Clinical Medicine (Hematology-Oncology)
28
76
3
5f
Attending Physician, Hospital of the University of Pennsylvania
76
Chair, Clinical Trials Scientific Research Monitoring Committee
79
Chair, Hospital University of Pennsylvania Credentialing Committee
5d
Lymphoma Section Chief, Division of Hem/Onc
18
Department of Medicine
7
11
Department: Medicine
4
1
b
1d
46
Contact information
4d
4
3
3
3
2
4
b
1f
4d
Division of Hematology Oncology
2d Perelman Center for Advanced Medicine
22 12th Floor, South Pavilion
16 Office #12-159
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
26
2d Perelman Center for Advanced Medicine
22 12th Floor, South Pavilion
16 Office #12-159
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
30
Office: 215-662-3933
32 Fax: 215-615-5887
24
f
32 Fax: 215-615-5887
24
13
Education:
21 7 BS 26 (Microbiology & Immunology) c
27 Stanford University, Palo Alto, CA 16 , 1991.
21 7 MD c
42 Medical College of Virginia, Richmond, VA, 1995.
c
3
3
3
3
8b
Permanent link21 7 BS 26 (Microbiology & Immunology) c
27 Stanford University, Palo Alto, CA 16 , 1991.
21 7 MD c
42 Medical College of Virginia, Richmond, VA, 1995.
c
2 29
21
1e
1d
24
5e
2b Clinical trials in Castleman Diseaes
65
50 2. Bone Marrow and Stem Cell Transplantation, autologous and allogeneic.
96 3. Special interest in treating patients with aggressive non-Hodgkin's lymphoma, lymphoma in the elderly and lymphoma in the pregnant patient.
70 4. Special interest in the long-term follow-up of patients with Hodgkin's lymphoma and survivors issues.
3c 5. Management of patients with histiocytic disorders
38 6. Management of patients with Castleman disease.
1a 29
27
Description of Research Expertise
4f Clinical trials in non-Hodgkin's lymphoma, phase I, II and III2b Clinical trials in Castleman Diseaes
65
Description of Clinical Expertise
dc 1.Management of patients with Non-Hodgkin's lymphoma, Hodgkin's Lymphoma, multiple myeloma, acute and chronic leukemias with standard therapy as well as clinical experimental therapies using new agents.50 2. Bone Marrow and Stem Cell Transplantation, autologous and allogeneic.
96 3. Special interest in treating patients with aggressive non-Hodgkin's lymphoma, lymphoma in the elderly and lymphoma in the pregnant patient.
70 4. Special interest in the long-term follow-up of patients with Hodgkin's lymphoma and survivors issues.
3c 5. Management of patients with histiocytic disorders
38 6. Management of patients with Castleman disease.
1a 29
23
eb Ward RE, Dave N, Pai EL, Colbourn R, Banihashemi A, Nasta SD, Babatunde VD.: Methotrexate-associated Peripheral Neuropathy on 18F-FDG PET/CT and MRI Masquerading as Neurolymphomatosis. 7d Clin Nucl Med. Page: Online ahead of print. Apr 18 2025 Notes: doi: 10.1097/RLU.0000000000005899.
d2 Potluri VS, Zhang S, Schaubel DE, Shaikhouni S, Blumberg EA, Nasta SD, Bloom RD, Cruz-Peralta M, Mehta RB, Lavu NR, Getachew B, Tandukar S, Reese PP, Puttarajappa CM. 106 : The Association of Epstein-Barr Virus Donor and Recipient Serostatus With Outcomes After Kidney Transplantation : A Retrospective Cohort Study. Ann Intern Med. 178(2): 157-166, Feb 2025 Notes: doi: 10.7326/ANNALS-24-00165. Online ahead of print. 1a PMID:
25d Stefan Barta, Stephen Schuster, Jakub Svoboda, Jordan Carter, Elise Chong, Daniel Landsburg, Sunita Nasta, Ruchi Patel, Joseph Fraietta, Colin Thomas, Aditya Nimmagadda, Lavanya Peddada, Adam Snook, Nicholas Siciliano, Marco Ruella, Rosemary Mazanet: CD5-deleted chimeric antigen receptor cells (Senza5 CART5) to enhance immunotherapy against T-cell non-Hodgkin lymphoma: A first-in-human phase I clinical trial (NCT06420089. American Society of Clinical Oncology Annual Meeting, Chicago, IL. June 2025 Notes: "Poster Presentation"
228 Saishravan Shyamsundar, Larissa Borys, Sheila Pierson, Mateo Sarmiento Bustamante, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan Lim, Gordan Srkalovic, Frits van Rhee, Sunita Nasta, Ariela Noy, Bridget Austin, Joshua Brandstadter, David Fajgenbaum: Variable response rates across chemotherapy regimens for severe idiopathic multicentric Castleman disease. American Society of Clinical Oncology Annual Meeting, Chicago, IL. June 2025 Notes: "Poster Presentation"
16c Nikita K. Dave, Paola Carvajal, Jordan S. Carter, Michael Cook, Colin Thomas, Donald E. Tsai, Stephen J. Schuster, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Daniel J. Landsburg, Sunita D. Nasta: Prolonged Methotrexate, Temozolomide and Rituximab in Secondary Central Nervous System Lymphoma 2 2 83 American Society of Clinical Oncology Annual Meeting, Chicago, IL. June 2025 Notes: "Poster Presentation"
1e3 Svoboda J, Landsburg DJ, Gerson J, Nasta SD, Barta SK, Chong EA, Cook M, Frey NV, Shea J, Cervini A, Marshall A, Four M, Davis MM, Jadlowsky JK, Chew A, Pequignot E, Gonzalez V, Noll JH, Paruzzo L, Rojas-Levine J, Plesa G, Scholler J, Siegel DL, Levine BL, Porter DL, Ghassemi S, Ruella M, Rech A, Leskowitz RM, Fraietta JA, Hwang WT, Hexner E, Schuster SJ, June CH.: Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure. 2 2 69 N Engl J Med. 392(18): 1824-1835, May 8 2025 Notes: doi: 10.1056/NEJMoa2408771.
19e Nikita K. Dave, Veronica Carvajal, Alex C. Watts, Jordan S. Carter, Michael Cook, Colin Thomas, Donald E. Tsai, Stephen J. Schuster, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Wei-Ting Hwang, Daniel J. Landsburg, Sunita D. Nasta: Outcomes at a Single Institution with MTR Induction and Consolidation in the Management of Primary CNS Lymphoma 2 45 Blood Neoplasia 2(3): 100102. Apr 2025 Notes: ISSN 2950-3280, 3f https://doi.org/10.1016/j.bneo.2025.100102.
11b Canty EA, Broderick L, Flaherty D, Xavier M, Nasta SD, Dajani L, White AA.: First reported case of a spontaneous and healthy pregnancy in a woman with persistent CAR T-cells 5 years after treatment for diffuse large B-cell lymphoma. 6f J Immunother Cancer. 13(4): e011092, Apr 1 2025 Notes: doi: 10.1136/jitc-2024-011092.
186 Pierson SK, Brandstadter JD, Torigian D, Bagg A, Lechowicz MJ, Alapat D MD, Casper C, Chadburn A, Chandrakasan S, Dispenzieri A, Fosså A, Hoffmann C, Ide M, Kurzrock R, Mukherjee S, Nasta SD, Navarro JT, Noy A, Oksenhendler E, Sarmiento Bustamante M, Shyamsundar S, Streetly MJ, Wong RSM, Zhang L, Lim MS, Srkalovic G, van Rhee F, Fajgenbaum DC. 109 : Characterizing the heterogeneity of Castleman disease and oligocentric subtype: Findings from the ACCELERATE registry. Blood Adv. 9(8): 1952-1965, Apr 2025 Notes: bloodadvances.2024014391. doi: 10.1182/bloodadvances.2024014391. Online ahead of print. 14
2c
7
1d
1f
Selected Publications
148 Elghawy O, Sussman JH, Yang AG, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK.: Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome. 6e JAMA Dermatol. 161(6): e250251, Jun 2025 Notes: doi: 10.1001/jamadermatol.2025.0251.eb Ward RE, Dave N, Pai EL, Colbourn R, Banihashemi A, Nasta SD, Babatunde VD.: Methotrexate-associated Peripheral Neuropathy on 18F-FDG PET/CT and MRI Masquerading as Neurolymphomatosis. 7d Clin Nucl Med. Page: Online ahead of print. Apr 18 2025 Notes: doi: 10.1097/RLU.0000000000005899.
d2 Potluri VS, Zhang S, Schaubel DE, Shaikhouni S, Blumberg EA, Nasta SD, Bloom RD, Cruz-Peralta M, Mehta RB, Lavu NR, Getachew B, Tandukar S, Reese PP, Puttarajappa CM. 106 : The Association of Epstein-Barr Virus Donor and Recipient Serostatus With Outcomes After Kidney Transplantation : A Retrospective Cohort Study. Ann Intern Med. 178(2): 157-166, Feb 2025 Notes: doi: 10.7326/ANNALS-24-00165. Online ahead of print. 1a PMID:
25d Stefan Barta, Stephen Schuster, Jakub Svoboda, Jordan Carter, Elise Chong, Daniel Landsburg, Sunita Nasta, Ruchi Patel, Joseph Fraietta, Colin Thomas, Aditya Nimmagadda, Lavanya Peddada, Adam Snook, Nicholas Siciliano, Marco Ruella, Rosemary Mazanet: CD5-deleted chimeric antigen receptor cells (Senza5 CART5) to enhance immunotherapy against T-cell non-Hodgkin lymphoma: A first-in-human phase I clinical trial (NCT06420089. American Society of Clinical Oncology Annual Meeting, Chicago, IL. June 2025 Notes: "Poster Presentation"
228 Saishravan Shyamsundar, Larissa Borys, Sheila Pierson, Mateo Sarmiento Bustamante, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan Lim, Gordan Srkalovic, Frits van Rhee, Sunita Nasta, Ariela Noy, Bridget Austin, Joshua Brandstadter, David Fajgenbaum: Variable response rates across chemotherapy regimens for severe idiopathic multicentric Castleman disease. American Society of Clinical Oncology Annual Meeting, Chicago, IL. June 2025 Notes: "Poster Presentation"
16c Nikita K. Dave, Paola Carvajal, Jordan S. Carter, Michael Cook, Colin Thomas, Donald E. Tsai, Stephen J. Schuster, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Daniel J. Landsburg, Sunita D. Nasta: Prolonged Methotrexate, Temozolomide and Rituximab in Secondary Central Nervous System Lymphoma 2 2 83 American Society of Clinical Oncology Annual Meeting, Chicago, IL. June 2025 Notes: "Poster Presentation"
1e3 Svoboda J, Landsburg DJ, Gerson J, Nasta SD, Barta SK, Chong EA, Cook M, Frey NV, Shea J, Cervini A, Marshall A, Four M, Davis MM, Jadlowsky JK, Chew A, Pequignot E, Gonzalez V, Noll JH, Paruzzo L, Rojas-Levine J, Plesa G, Scholler J, Siegel DL, Levine BL, Porter DL, Ghassemi S, Ruella M, Rech A, Leskowitz RM, Fraietta JA, Hwang WT, Hexner E, Schuster SJ, June CH.: Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure. 2 2 69 N Engl J Med. 392(18): 1824-1835, May 8 2025 Notes: doi: 10.1056/NEJMoa2408771.
19e Nikita K. Dave, Veronica Carvajal, Alex C. Watts, Jordan S. Carter, Michael Cook, Colin Thomas, Donald E. Tsai, Stephen J. Schuster, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Wei-Ting Hwang, Daniel J. Landsburg, Sunita D. Nasta: Outcomes at a Single Institution with MTR Induction and Consolidation in the Management of Primary CNS Lymphoma 2 45 Blood Neoplasia 2(3): 100102. Apr 2025 Notes: ISSN 2950-3280, 3f https://doi.org/10.1016/j.bneo.2025.100102.
11b Canty EA, Broderick L, Flaherty D, Xavier M, Nasta SD, Dajani L, White AA.: First reported case of a spontaneous and healthy pregnancy in a woman with persistent CAR T-cells 5 years after treatment for diffuse large B-cell lymphoma. 6f J Immunother Cancer. 13(4): e011092, Apr 1 2025 Notes: doi: 10.1136/jitc-2024-011092.
186 Pierson SK, Brandstadter JD, Torigian D, Bagg A, Lechowicz MJ, Alapat D MD, Casper C, Chadburn A, Chandrakasan S, Dispenzieri A, Fosså A, Hoffmann C, Ide M, Kurzrock R, Mukherjee S, Nasta SD, Navarro JT, Noy A, Oksenhendler E, Sarmiento Bustamante M, Shyamsundar S, Streetly MJ, Wong RSM, Zhang L, Lim MS, Srkalovic G, van Rhee F, Fajgenbaum DC. 109 : Characterizing the heterogeneity of Castleman disease and oligocentric subtype: Findings from the ACCELERATE registry. Blood Adv. 9(8): 1952-1965, Apr 2025 Notes: bloodadvances.2024014391. doi: 10.1182/bloodadvances.2024014391. Online ahead of print. 14
2c